Cross Country Healthcare announced strong second quarter 2022 results with revenue increasing 127% year-over-year to $753.6 million and net income attributable to common stockholders increasing 358% year-over-year to $52.9 million.
Revenue and Adjusted EBITDA exceeded guidance ranges
Record number of professionals on assignment
Double-digit year-over-year growth across all lines of business
Adjusted EBITDA margin of 11.1%
The guidance below applies to management’s expectations for the third quarter of 2022.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance